プロモーションスケジュール MiNK Therapeutics, Inc.
詳細なスケジュール
簡易グラフ
会社について MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It's product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York.| IPO date | 2021-10-15 |
|---|---|
| ISIN | US6036931029 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://minktherapeutics.com |
| Цена ао | 9.32 |
| 1日あたりの価格変動: | -1.65% (9.1) |
|---|---|
| 週ごとの価格変動: | -11.39% (10.1) |
| 月ごとの料金変更: | +35.61% (6.6) |
| 3ヶ月間の価格変動: | +22.17% (7.326) |
| 半年間の価格変動: | +9.16% (8.199) |
| 年間の価格変動: | +842.11% (0.95) |
| 3年間の価格推移: | +211.85% (2.87) |
| 5年間の価格推移: | 0% (8.95) |
| 10年間の価格推移: | 0% (8.95) |
| 年初からの価格変動: | +93.22% (4.632) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| 機関 | 音量 | 共有, % |
|---|---|---|
| Vanguard Group Inc | 234182 | 0.67 |
| Longbow Finance Sa | 166666 | 0.48 |
| Renaissance Technologies, LLC | 92041 | 0.27 |
| Geode Capital Management, LLC | 90164 | 0.26 |
| Blackrock Inc. | 76457 | 0.22 |
| CapTrust Financial Advisors | 54291 | 0.16 |
| HighTower Advisors, LLC | 50941 | 0.15 |
| Citadel Advisors Llc | 42141 | 0.12 |
| Oracle Investment Management Inc | 36898 | 0.11 |
| State Street Corporation | 25700 | 0.07 |
| ETF | 共有, % | 年間の利益率, % | 配当金, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.00188 | 17.09 | 1.54048 |
| 0.00000 | 17.09 | 1.54 |
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Dr. Garo H. Armen Ph.D. | Executive Chairman | N/A | 1953 (72 年) |
| Dr. Jennifer S. Buell Ph.D. | President, CEO & Director | 916.75k | 1975 (50 年) |
| Dr. Marcus Antonius van Dijk Ph.D. | Chief Scientific Officer | 458.28k | 1962 (63 年) |
| Ms. Christine M. Klaskin | Treasurer | 29.62k | 1966 (59 年) |
| Joy Zhou Ph.D. | Vice President & Head of CMC | N/A | |
| Mr. Robert Foster | Director Of Legal & Business Affairs |
住所: United States, New York. NY, 149 Fifth Avenue - Googleマップで開く, Yandexマップを開く
Webサイト: https://minktherapeutics.com
Webサイト: https://minktherapeutics.com
